Henry Ford Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Henry Ford Health System sits in the top decile of US sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count).
Henry Ford Health System: 234 sponsored US clinical trials, 43 recruiting.
Henry Ford Health System sponsors 234 registered US clinical trials on ClinicalTrials.gov, 43 of them currently recruiting, and 148 completed. 35 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Insomnia, with 5 trials.
Top-decile sponsor footprint
Henry Ford Health System ranks in the top decile of sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
148 of 173 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
234 total, page 4 of 5
Suvorexant in Insomnia Co-morbid With Fibromyalgia
NCT02684136
Intrathoracic Esophagogastric Anastomosis After Robot Assisted Minimally Invasive Esophagectomy Using STRATAFIX
NCT02609425
Safety and Efficacy of Chronic Hypnotic Use 2
NCT02456532
Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer
NCT02555397
Teen Asthma Control Encouraging a Healthier Lifestyle
NCT02575326
Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters
NCT05256147
The Effects of Visible Light on the Skin After Administration of Oral Polypodium Leucotomos
NCT02904798
Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy
NCT02496260
Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI
NCT02499666
Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique
NCT02814721
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
NCT02163746
Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)
NCT02339974
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
NCT02352103
Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement
NCT03117296
Current Scope of Practice of Today's Hepatopancreatobiliary Surgeons: A Survey of AHPBA Members
NCT05075733
Liposomal Bupivacaine in Total Shoulder Arthroplasty
NCT02570022
Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis
NCT03851601
Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation
NCT06584370
Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy
NCT02155595
Encouraging Young Adults to Make Effective Nutrition Choices
NCT01979809
Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke
NCT02056821
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
NCT02243358
Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit
NCT02025855
Comparison of Scar Results and Time for Closures of Scalp Defects Via Pulley Sutures or Layered Repairs
NCT02744950
Comparison of Traditional Superficial Cutaneous Sutures Versus Steri-Strip Coaptive Film in Layered Dermatologic Closures
NCT01938586
Cardiology-Emergency Medicine Cardiac Biomarker Research Initiative
NCT01984853
Web-Based and Tailored Asthma Management Intervention (Puff City) in Teens With Asthma Attending Urban Clinics
NCT01757002
NB-UVB and PUVA Vitiligo Study
NCT01732965
An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.
NCT01818167
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
NCT01683955
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens
NCT01695031
Pilot Evaluation of the JHI Platform
NCT01648673
Female Acl Prevention Study Where we Look at Landing Techniques Pre/Post Nine Week Strenghtening Program
NCT01729312
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
NCT01734694
Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B
NCT01429155
Utility of Interface Pressure Mapping
NCT01439581
Higher Intensity Interval Training in Cardiac Rehabilitation
NCT01606696
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
NCT01370460
Cardiac Rehabilitation in Patients With Continuous Flow Left Ventricular Assist Devices:Rehab VAD Trial
NCT01584895
Post-Exposure Prophylaxis in Health Care Workers
NCT01234116
Readiness for Behavior Change After a Heart Attack
NCT01596036
Association Between Hepatitis C Infection and Renal Cell Carcinoma
NCT01405183
Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
NCT05718466
Vaginal Cuff Closure in Robotic Hysterectomy
NCT02696239
PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
NCT01208077
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
NCT01063270
Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar
NCT01125137
Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions
NCT02135744
Regenerative Tissue Matrix for Breast Reconstruction
NCT01027637
Effects of Botulinum Toxin in Cervical Dystonia
NCT01056861
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 23 |
| Phase 3 | 9 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the Henry Ford Health System pipeline
43 recruiting of 234 indexed (18% open); 148 completed (63%).
Phase mix: 35 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Insomnia (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Henry Ford Health System: open-pipeline peers nationwide
Peers matched on 234 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 234 trials (± recruiting share)
- Daiichi Sankyo · 236 trials · 12% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Brown University · 231 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- New York Institute of Technology · 18% recruiting · 49 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this Henry Ford Health System page
234 registered trials is a research-attention snapshot, not an endorsement of Henry Ford Health System or any single study.
- 43 of Henry Ford Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Insomnia is the condition Henry Ford Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Insomnia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Henry Ford Health System pipeline card: 234 registered trials from official public datasets.Report a data error.